Similar articles for PMID: 10071170

Year	Number of Results
1983	3
1984	2
1985	2
1986	4
1987	5
1988	3
1989	3
1990	5
1991	2
1992	2
1993	3
1994	2
1995	2
1996	4
1997	2
1999	4
2000	3
2002	1
2003	2
2004	4
2005	3
2006	1
2007	2
2009	1
2012	1
2018	1
2024	0

1

The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA.

Warren G, McKendrick M, Peet M. Warren G, et al. Acta Neurol Scand. 1999 Feb;99(2):112-6. doi: 10.1111/j.1600-0404.1999.tb00667.x. Acta Neurol Scand. 1999. PMID: 10071170 Clinical Trial.

2

Effect of high doses of essential fatty acids on the postviral fatigue syndrome.

Behan PO, Behan WM, Horrobin D. Behan PO, et al. Acta Neurol Scand. 1990 Sep;82(3):209-16. doi: 10.1111/j.1600-0404.1990.tb04490.x. Acta Neurol Scand. 1990. PMID: 2270749 Clinical Trial.

3

Effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandins in old subjects.

Hornych A, Girault F, Oravec S, Forette B, Horrobin DF. Hornych A, et al. Br J Clin Pharmacol. 1999 Dec;48(6):869-70. Br J Clin Pharmacol. 1999. PMID: 10651470 Free article. No abstract available.

4

Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis.

Horrobin DF. Horrobin DF. Scand J Rheumatol Suppl. 1986;61:242-5. Scand J Rheumatol Suppl. 1986. PMID: 3296151 Review.

5

Effect of different ratios of dietary N-6 and N-3 fatty acids on fatty acid composition, prostaglandin formation and platelet aggregation in the rat.

Takahashi R, Nassar BA, Huang YS, Begin ME, Horrobin DF. Takahashi R, et al. Thromb Res. 1987 Jul 15;47(2):135-46. doi: 10.1016/0049-3848(87)90370-7. Thromb Res. 1987. PMID: 3660347

6

A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis.

Veale DJ, Torley HI, Richards IM, O'Dowd A, Fitzsimons C, Belch JJ, Sturrock RD. Veale DJ, et al. Br J Rheumatol. 1994 Oct;33(10):954-8. doi: 10.1093/rheumatology/33.10.954. Br J Rheumatol. 1994. PMID: 7921757 Clinical Trial.

7

The effects of essential fatty acid supplementation by Efamol in hyperactive children.

Aman MG, Mitchell EA, Turbott SH. Aman MG, et al. J Abnorm Child Psychol. 1987 Mar;15(1):75-90. doi: 10.1007/BF00916467. J Abnorm Child Psychol. 1987. PMID: 3553274 Clinical Trial.

8

Patients with primary Sjögren's syndrome treated for two months with evening primrose oil.

Oxholm P, Manthorpe R, Prause JU, Horrobin D. Oxholm P, et al. Scand J Rheumatol. 1986;15(2):103-8. doi: 10.3109/03009748609102073. Scand J Rheumatol. 1986. PMID: 3529370 Clinical Trial.

9

Membrane fatty acids, niacin flushing and clinical parameters.

Glen AI, Cooper SJ, Rybakowski J, Vaddadi K, Brayshaw N, Horrobin DF. Glen AI, et al. Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):9-15. doi: 10.1016/s0952-3278(96)90139-8. Prostaglandins Leukot Essent Fatty Acids. 1996. PMID: 8888117 Clinical Trial.

10

Essential fatty acids in the plasma phospholipids of patients with atopic eczema.

Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL. Manku MS, et al. Br J Dermatol. 1984 Jun;110(6):643-8. doi: 10.1111/j.1365-2133.1984.tb04698.x. Br J Dermatol. 1984. PMID: 6329254 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year